Herva ME - Search Results

1

Anti-amyloid compounds inhibit α-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA).

Herva ME, Zibaee S, Fraser G, Barker RA, Goedert M, Spillantini MG. Herva ME, et al. J Biol Chem. 2014 Apr 25;289(17):11897-11905. doi: 10.1074/jbc.M113.542340. Epub 2014 Feb 28. J Biol Chem. 2014. PMID: 24584936 Free PMC article.

2

Parkinson's disease as a member of Prion-like disorders.

Herva ME, Spillantini MG. Herva ME, et al. Virus Res. 2015 Sep 2;207:38-46. doi: 10.1016/j.virusres.2014.10.016. Epub 2014 Nov 4. Virus Res. 2015. PMID: 25456401 Review.

3

Influence of Drug-Carrier Polymers on Alpha-Synucleinopathies: A Neglected Aspect in New Therapies Development.

Tonda-Turo C, Herva M, Chiono V, Ciardelli G, Spillantini MG. Tonda-Turo C, et al. Biomed Res Int. 2018 Feb 21;2018:4518060. doi: 10.1155/2018/4518060. eCollection 2018. Biomed Res Int. 2018. PMID: 29686999 Free PMC article.

4

Abrogation of complex glycosylation by swainsonine results in strain- and cell-specific inhibition of prion replication.

Browning S, Baker CA, Smith E, Mahal SP, Herva ME, Demczyk CA, Li J, Weissmann C. Browning S, et al. Among authors: herva me. J Biol Chem. 2011 Nov 25;286(47):40962-73. doi: 10.1074/jbc.M111.283978. Epub 2011 Sep 19. J Biol Chem. 2011. PMID: 21930694 Free PMC article.

5

Propagation of RML prions in mice expressing PrP devoid of GPI anchor leads to formation of a novel, stable prion strain.

Mahal SP, Jablonski J, Suponitsky-Kroyter I, Oelschlegel AM, Herva ME, Oldstone M, Weissmann C. Mahal SP, et al. Among authors: herva me. PLoS Pathog. 2012;8(6):e1002746. doi: 10.1371/journal.ppat.1002746. Epub 2012 Jun 7. PLoS Pathog. 2012. PMID: 22685404 Free PMC article.

6

Cell-specific susceptibility to prion strains is a property of the intact cell.

Herva ME, Weissman C. Herva ME, et al. Prion. 2012 Sep-Oct;6(4):371-4. doi: 10.4161/pri.20198. Epub 2012 May 11. Prion. 2012. PMID: 22561192 Free PMC article.

7

Prion infection of differentiated neurospheres.

Herva ME, Relaño-Ginés A, Villa A, Torres JM. Herva ME, et al. J Neurosci Methods. 2010 May 15;188(2):270-5. doi: 10.1016/j.jneumeth.2010.02.022. Epub 2010 Mar 3. J Neurosci Methods. 2010. PMID: 20206206

8

Dysfunction of the PI3K-Akt-GSK-3 pathway is a common feature in cell culture and in vivo models of prion disease.

Simon D, Herva ME, Benitez MJ, Garrido JJ, Rojo AI, Cuadrado A, Torres JM, Wandosell F. Simon D, et al. Among authors: herva me. Neuropathol Appl Neurobiol. 2014 Apr;40(3):311-26. doi: 10.1111/nan.12066. Neuropathol Appl Neurobiol. 2014. PMID: 23741998

9

Elements modulating the prion species barrier and its passage consequences.

Torres JM, Espinosa JC, Aguilar-Calvo P, Herva ME, Relaño-Ginés A, Villa-Diaz A, Morales M, Parra B, Alamillo E, Brun A, Castilla J, Molina S, Hawkins SA, Andreoletti O. Torres JM, et al. Among authors: herva me. PLoS One. 2014 Mar 7;9(3):e89722. doi: 10.1371/journal.pone.0089722. eCollection 2014. PLoS One. 2014. PMID: 24608126 Free PMC article.

10

Transgenic mice expressing porcine prion protein resistant to classical scrapie but susceptible to sheep bovine spongiform encephalopathy and atypical scrapie.

Espinosa JC, Herva ME, Andréoletti O, Padilla D, Lacroux C, Cassard H, Lantier I, Castilla J, Torres JM. Espinosa JC, et al. Among authors: herva me. Emerg Infect Dis. 2009 Aug;15(8):1214-21. doi: 10.3201/eid1508.081218. Emerg Infect Dis. 2009. PMID: 19751582 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page